Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4496)
All Articles published online
|
Dec 7, 2009 (publication date) through Jan 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15(45): 5633-5640 [PMID: 19960558 DOI: 10.3748/wjg.15.5633] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i45/5633.htm |
| Number | Citing Articles |
| 1 |
Fatemeh Momen-Heravi, Shashi Bala. Molecular Aspects of Alcohol and Nutrition. 2016; : 275 doi: 10.1016/B978-0-12-800773-0.00022-7
|
| 2 |
Mario Alberto Burgos-Aceves, Amit Cohen, Gaetana Paolella, Marilena Lepretti, Yoav Smith, Caterina Faggio, Lillà Lionetti. Modulation of mitochondrial functions by xenobiotic-induced microRNA: From environmental sentinel organisms to mammals. Science of The Total Environment 2018; 645: 79 doi: 10.1016/j.scitotenv.2018.07.109
|
| 3 |
Alessandra Mescalchin, Tobias Restle. Oligomeric Nucleic Acids as Antivirals. Molecules 2011; 16(2): 1271 doi: 10.3390/molecules16021271
|
| 4 |
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
|
| 5 |
U Singh, N Keirstead, A Wolujczyk, M Odin, M Albassam, R Garrido. General principles and methods for routine automated microRNA in situ hybridization and double labeling with immunohistochemistry. Biotechnic & Histochemistry 2014; 89(4): 259 doi: 10.3109/10520295.2013.839825
|
| 6 |
Sarmistha Bandyopadhyay, Robin C. Friedman, Rebecca T. Marquez, Kathy Keck, Benjamin Kong, Michael S. Icardi, Kyle E. Brown, Christopher B. Burge, Warren N. Schmidt, Yulei Wang, Anton P. McCaffrey. Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture. The Journal of Infectious Diseases 2011; 203(12): 1753 doi: 10.1093/infdis/jir186
|
| 7 |
Fei Xiao, Junjie Yu, Bin Liu, Yajie Guo, Kai Li, Jiali Deng, Jin Zhang, Chunxia Wang, Shanghai Chen, Ying Du, Yingli Lu, Yuzhong Xiao, Zhou Zhang, Feifan Guo. A Novel Function of MicroRNA 130a-3p in Hepatic Insulin Sensitivity and Liver Steatosis. Diabetes 2014; 63(8): 2631 doi: 10.2337/db13-1689
|
| 8 |
Julian Krauskopf, Almudena Espín-Pérez, Jos C. Kleinjans, Theo M. de Kok. Protocols in In Vitro Hepatocyte Research. Methods in Molecular Biology 2015; 1250: 241 doi: 10.1007/978-1-4939-2074-7_17
|
| 9 |
E. Boštjančič, E. Bandelj, B. Luzar, M. Poljak, D. Glavač. Hepatic expression of miR‐122, miR‐126, miR‐136 and miR‐181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C. Journal of Viral Hepatitis 2015; 22(2): 146 doi: 10.1111/jvh.12266
|
| 10 |
Sander van den Driesche, Richard M. Sharpe, Philippa T.K. Saunders, Rod T. Mitchell. Regulation of the germ stem cell niche as the foundation for adult spermatogenesis: A role for miRNAs?. Seminars in Cell & Developmental Biology 2014; 29: 76 doi: 10.1016/j.semcdb.2014.04.006
|
| 11 |
E. Abdelmageed Marzook, A.F. Abdel-Aziz, A.E. Abd El-Moneim, H.A. Mansour, K.S. Atia, N.A. Salah. MicroRNA-122 expression in hepatotoxic and γ-irradiated rats pre-treated with naringin and silymarin. Journal of Radiation Research and Applied Sciences 2020; 13(1): 38 doi: 10.1080/16878507.2019.1695392
|
| 12 |
Sakura Akamatsu, C. Nelson Hayes, Masataka Tsuge, Daiki Miki, Rie Akiyama, Hiromi Abe, Hidenori Ochi, Nobuhiko Hiraga, Michio Imamura, Shoichi Takahashi, Hiroshi Aikata, Tomokazu Kawaoka, Yoshiiku Kawakami, Waka Ohishi, Kazuaki Chayama. Differences in serum microRNA profiles in hepatitis B and C virus infection. Journal of Infection 2015; 70(3): 273 doi: 10.1016/j.jinf.2014.10.017
|
| 13 |
Amir Ajoolabady, Hamid Aslkhodapasandhokmabad, Yuan Zhou, Jun Ren. Epigenetic modification in alcohol‐related liver diseases. Medicinal Research Reviews 2022; 42(4): 1463 doi: 10.1002/med.21881
|
| 14 |
Subramanian Saravanan, Krishnaraj Thirugnanasambantham, Hamza Hanieh, Kulandaivelu Karikalan, Durairaj Sekar, Rukkumani Rajagopalan, Villianur Ibrahim Hairul Islam. miRNA-24 and miRNA-466i-5p controls inflammation in rat hepatocytes. Cellular & Molecular Immunology 2015; 12(1): 113 doi: 10.1038/cmi.2014.67
|
| 15 |
Chuanshan Zhang, Limin Wang, Tuergan Ali, Liang Li, Xiaojuan Bi, Junhua Wang, Guodong Lü, Yingmei Shao, Dominique A. Vuitton, Hao Wen, Renyong Lin. Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression. Parasites & Vectors 2016; 9(1) doi: 10.1186/s13071-016-1562-x
|
| 16 |
Attia Fatima, David J Lynn, Padraic O’Boyle, Cathal Seoighe, Dermot Morris. The miRNAome of the postpartum dairy cow liver in negative energy balance. BMC Genomics 2014; 15(1) doi: 10.1186/1471-2164-15-279
|
| 17 |
Kevin Tak-Pan NG, Chung Mau Lo, Nathalie Wong, Chang Xian Li, Xiang Qi, Xiao Bing Liu, Wei Geng, Oscar Wai-Ho Yeung, Yuen Yuen Ma, See Ching Chan, Kwan Man. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Oncotarget 2016; 7(15): 19824 doi: 10.18632/oncotarget.7627
|
| 18 |
Keiko Arataki, C. Nelson Hayes, Sakura Akamatsu, Rie Akiyama, Hiromi Abe, Masataka Tsuge, Daiki Miki, Hidenori Ochi, Nobuhiko Hiraga, Michio Imamura, Shoichi Takahashi, Hiroshi Aikata, Tomokazu Kawaoka, Hiroiku Kawakami, Waka Ohishi, Kazuaki Chayama. Circulating microRNA‐22 correlates with microRNA‐122 and represents viral replication and liver injury in patients with chronic hepatitis B. Journal of Medical Virology 2013; 85(5): 789 doi: 10.1002/jmv.23540
|
| 19 |
Yasmeen Ishaq, Aqsa Ikram, Badr Alzahrani, Sana Khurshid. The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Insilico Approach. Genes 2022; 14(1): 13 doi: 10.3390/genes14010013
|
| 20 |
Shashi Bala, Gyongyi Szabo. MicroRNA Signature in Alcoholic Liver Disease. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/498232
|
| 21 |
Manuele Gori, Mario Arciello, Clara Balsano. MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/741465
|
| 22 |
Wafaa M. Ezzat, Khalda Said Amr, Yasser A. Elhosary, Abdelfattah E. Hegazy, Hoda H. Fahim, Noha H. Eltaweel, Refaat R. Kamel. Detection of DNA methylated microRNAs in hepatocellular carcinoma. Gene 2019; 702: 153 doi: 10.1016/j.gene.2019.02.080
|
| 23 |
Hiresh Ayoubian, Joana Heinzelmann, Sebastian Hölters, Oybek Khalmurzaev, Alexey Pryalukhin, Philine Loertzer, Julia Heinzelbecker, Stefan Lohse, Carol Geppert, Hagen Loertzer, Heiko Wunderlich, Rainer M. Bohle, Michael Stöckle, Vsevolod Borisovich Matveev, Arndt Hartmann, Kerstin Junker. miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma. Cancers 2021; 13(6): 1480 doi: 10.3390/cancers13061480
|
| 24 |
Chiu-Chun Chang, Chun-Che Lin, Wan-Ling Hsieh, Hsin-Wu Lai, Chia-Hsun Tsai, Ya-Wen Cheng. MicroRNA Expression Profiling in PBMCs: A Potential Diagnostic Biomarker of Chronic Hepatitis C. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/367157
|
| 25 |
Dhamotharan Pattarayan, Rajesh K. Thimmulappa, Vilwanathan Ravikumar, Subbiah Rajasekaran. Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases. Clinical Reviews in Allergy & Immunology 2018; 54(3): 480 doi: 10.1007/s12016-016-8589-9
|
| 26 |
Hitarthi S. Vyas, Kapil K. Upadhyay, Ranjitsinh V. Devkar. miRNAs Signatures In Patients With Acute Liver Injury: Clinical Concerns and Correlations. Current Molecular Medicine 2020; 20(5): 325 doi: 10.2174/1566524020666191211153546
|
| 27 |
Shalini R. Dubey, Tester F. Ashavaid, Philip Abraham, Minal Umesh Paradkar. Factors influencing circulating microRNAs as biomarkers for liver diseases. Molecular Biology Reports 2022; 49(6): 4999 doi: 10.1007/s11033-022-07170-1
|
| 28 |
Hebatallah Husseini Atteia. MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic
Mechanism and Early Diagnosis to Therapeutic Targeting by Natural
Products. Current Pharmaceutical Biotechnology 2024; 25(14): 1791 doi: 10.2174/0113892010282155231222071903
|
| 29 |
Cristian Turato, Davide Simonato, Santina Quarta, Angelo Gatta, Patrizia Pontisso. MicroRNAs and SerpinB3 in hepatocellular carcinoma. Life Sciences 2014; 100(1): 9 doi: 10.1016/j.lfs.2014.01.073
|
| 30 |
Nihar Shah, James E. Nelson, Kris V. Kowdley. MicroRNAs in Liver Disease: Bench to Bedside. Journal of Clinical and Experimental Hepatology 2013; 3(3): 231 doi: 10.1016/j.jceh.2013.09.001
|
| 31 |
Jun Xu, Xiao Liu, Bin Gao, Michael Karin, Hidekazu Tsukamoto, David Brenner, Tatiana Kisseleva. New Approaches for Studying Alcoholic Liver Disease. Current Pathobiology Reports 2014; 2(4): 171 doi: 10.1007/s40139-014-0053-z
|
| 32 |
Verónica Saludes, Irene Latorre, Andreas Meyerhans, Juana Díez. Nucleic Acids as Molecular Diagnostics. 2014; : 217 doi: 10.1002/9783527672165.ch10
|
| 33 |
Lili Guo, Xiang Yang, Tao Duan. Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse model. The Journal of Maternal-Fetal & Neonatal Medicine 2012; 25(10): 2071 doi: 10.3109/14767058.2012.678431
|
| 34 |
Valentina A. Schmidt. Watch the GAP: Emerging Roles for IQ Motif-Containing GTPase-Activating Proteins IQGAPs in Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/958673
|
| 35 |
Irma Karabegović, Yasir Abozaid, Silvana CE Maas, Jeremy Labrecque, Daniel Bos, Robert J De Knegt, M Arfan Ikram, Trudy Voortman, Mohsen Ghanbari. Plasma MicroRNA Signature of Alcohol Consumption: The Rotterdam Study. The Journal of Nutrition 2022; 152(12): 2677 doi: 10.1093/jn/nxac216
|
| 36 |
Elizabeth Brandon-Warner, Nicole A. Feilen, Catherine R. Culberson, Conroy O. Field, Andrew S. deLemos, Mark W. Russo, Laura W. Schrum. Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury. Alcoholism: Clinical and Experimental Research 2016; 40(7): 1430 doi: 10.1111/acer.13116
|
| 37 |
Mohammad Borji, Mitra Nourbakhsh, Sayed Mohammad Shafiee, Ali Akbar Owji, Zohreh Abdolvahabi, Zahra Hesari, Davod Ilbeigi, Parvaneh Seiri, Zeynab Yousefi. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells. Biochemical Genetics 2019; 57(4): 507 doi: 10.1007/s10528-019-09905-5
|
| 38 |
Yoshihiko Chiba, Takao Hijikata. MicroRNAs and Their Therapeutic Potential for Human Diseases: Preface. Journal of Pharmacological Sciences 2010; 114(3): 262 doi: 10.1254/jphs.10R09FM
|
| 39 |
Tai-You Ha. MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease. Immune Network 2011; 11(6): 309 doi: 10.4110/in.2011.11.6.309
|
| 40 |
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy, Ahmed E. Elesawy, Mahmoud A. Elrebehy, Reem K. Shahin, Heba M. Midan, Al-Aliaa M. Sallam. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. Pathology - Research and Practice 2023; 243: 154375 doi: 10.1016/j.prp.2023.154375
|
| 41 |
Denis Delić, Mohamed Dkhil, Saleh Al-Quraishy, Frank Wunderlich. Hepatic miRNA expression reprogrammed by Plasmodium chabaudi malaria. Parasitology Research 2011; 108(5): 1111 doi: 10.1007/s00436-010-2152-z
|
| 42 |
Costas Koufaris, Jayne Wright, Richard A. Currie, Nigel J. Gooderham. Hepatic MicroRNA Profiles Offer Predictive and Mechanistic Insights After Exposure to Genotoxic and Epigenetic Hepatocarcinogens. Toxicological Sciences 2012; 128(2): 532 doi: 10.1093/toxsci/kfs170
|
| 43 |
Reshmi Chatterjee, Abhisek Mitra. An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. International Immunopharmacology 2015; 24(2): 335 doi: 10.1016/j.intimp.2014.12.024
|
| 44 |
Chaoliang Tang, Hao Chen, Lai Jiang, Lianxin Liu, Andleeb Khan. Liver Regeneration: Changes in Oxidative Stress, Immune System, Cytokines, and Epigenetic Modifications Associated with Aging. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/9018811
|
| 45 |
Joshua C. Kwekel, Vikrant Vijay, Tao Han, Carrie L. Moland, Varsha G. Desai, James C. Fuscoe. Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biology of Sex Differences 2017; 8(1) doi: 10.1186/s13293-017-0127-9
|
| 46 |
Tomoko Tadokoro, Asahiro Morishita, Teppei Sakamoto, Shintaro Fujihara, Koji Fujita, Shima Mimura, Kyoko Oura, Takako Nomura, Joji Tani, Hirohito Yoneyama, Hisakazu Iwama, Takashi Himoto, Toshiro Niki, Mitsuomi Hirashima, Tsutomu Masaki. Galectin-9 ameliorates fulminant liver injury. Molecular Medicine Reports 2017; 16(1): 36 doi: 10.3892/mmr.2017.6606
|
| 47 |
Ramona G. Dumitrescu. Cancer Epigenetics for Precision Medicine. Methods in Molecular Biology 2018; 1856: 157 doi: 10.1007/978-1-4939-8751-1_9
|
| 48 |
Christopher Binny, Marco Della Peruta, Amit C. Nathwani. Clinical Dilemmas in Primary Liver Cancer. 2011; : 184 doi: 10.1002/9781119962205.ch26
|
| 49 |
Nourhan Abu-Shahba, Elsayed Hegazy, Faiz M. Khan, Mahmoud Elhefnawi. In Silico Analysis of MicroRNA Expression Data in Liver Cancer. Cancer Informatics 2023; 22 doi: 10.1177/11769351231171743
|
| 50 |
Robert C. Huebert, Kumaravelu Jagavelu, Helen I. Hendrickson, Meher M. Vasdev, Juan P. Arab, Patrick L. Splinter, Christy E. Trussoni, Nicholas F. LaRusso, Vijay H. Shah. Aquaporin-1 Promotes Angiogenesis, Fibrosis, and Portal Hypertension Through Mechanisms Dependent on Osmotically Sensitive MicroRNAs. The American Journal of Pathology 2011; 179(4): 1851 doi: 10.1016/j.ajpath.2011.06.045
|
| 51 |
Attia Fatima, Sinead Waters, Padraig O’Boyle, Cathal Seoighe, Dermot G Morris. Alterations in hepatic miRNA expression during negative energy balance in postpartum dairy cattle. BMC Genomics 2014; 15(1) doi: 10.1186/1471-2164-15-28
|
| 52 |
Vicky Nicolaidou, Costas Koufaris. MicroRNA responses to environmental liver carcinogens: Biological and clinical significance. Clinica Chimica Acta 2015; 445: 25 doi: 10.1016/j.cca.2015.03.006
|
| 53 |
Anatoliy I. Masyuk, Bing Q. Huang, Christopher J. Ward, Sergio A. Gradilone, Jesus M. Banales, Tatyana V. Masyuk, Brynn Radtke, Patrick L. Splinter, Nicholas F. LaRusso. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 299(4): G990 doi: 10.1152/ajpgi.00093.2010
|
| 54 |
Magdalena Filipowicz. Prognostic potential of hepatic miR-122 measurements and antisense strategies targeting miR-122 as a therapeutic approach in viral hepatitis. Liver International 2011; 31(4): 437 doi: 10.1111/j.1478-3231.2011.02476.x
|
| 55 |
Elizabeth Brandon-Warner, Jennifer H. Benbow, Jacob H. Swet, Nicole A. Feilen, Catherine R. Culberson, Iain H. McKillop, Andrew S. deLemos, Mark W. Russo, Laura W. Schrum. Adeno-Associated Virus Serotype 2 Vector–Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Human Gene Therapy 2018; 29(6): 674 doi: 10.1089/hum.2017.035
|
| 56 |
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 423 doi: 10.1007/978-3-030-11748-1_16
|
| 57 |
Bin Gao, Ramon Bataller. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology 2011; 141(5): 1572 doi: 10.1053/j.gastro.2011.09.002
|
| 58 |
María N. Lardizábal, Ana L. Nocito, Stella M. Daniele, Leonardo A. Ornella, Javier F. Palatnik, Luis M. Veggi, Kwan Man. Reference Genes for Real-Time PCR Quantification of MicroRNAs and Messenger RNAs in Rat Models of Hepatotoxicity. PLoS ONE 2012; 7(5): e36323 doi: 10.1371/journal.pone.0036323
|
| 59 |
Dany Anglicheau, Thangamani Muthukumar, Manikkam Suthanthiran. MicroRNAs: Small RNAs With Big Effects. Transplantation 2010; 90(2): 105 doi: 10.1097/TP.0b013e3181e913c2
|
| 60 |
Mahmoud ElHefnawi, Bangli Soliman, Nourhan Abu-Shahba, Marwa Amer. An Integrative Meta-Analysis of MicroRNAs in Hepatocellular Carcinoma. Genomics, Proteomics & Bioinformatics 2013; 11(6): 354 doi: 10.1016/j.gpb.2013.05.007
|
| 61 |
Maryam Shafaati, Mohammadreza Salehi, Maryam Zare. Liver Cancer - Multidisciplinary Approach. 2024; doi: 10.5772/intechopen.1005068
|
| 62 |
Min Ki Jee, Jin Sun Jung, Jee In Choi, Jin Ah Jang, Kyung Sun Kang, Young Bin Im, Soo Kyung Kang. MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury. Brain 2012; 135(4): 1237 doi: 10.1093/brain/aws047
|
| 63 |
Xing He, Guangbin Pu, Rui Tang, Dongmei Zhang, Weiqing Pan, Anna Alisi. Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica. PLoS ONE 2014; 9(8): e104323 doi: 10.1371/journal.pone.0104323
|
| 64 |
Zsuzsa Schaff, Ilona Kovalszky, Gábor Lotz, András Kiss. Hepatocellular carcinoma – from macroscopy to molecular pathology. Orvosi Hetilap 2010; 151(24): 982 doi: 10.1556/oh.2010.28875
|
| 65 |
P. Brzuzan, M. Woźny, L. Wolińska-Nizioł, A. Piasecka, M. Florczyk, E. Jakimiuk, M. Góra, M.K. Łuczyński, M. Gajęcki. MicroRNA expression profiles in liver and colon of sexually immature gilts after exposure to Fusarium mycotoxins. Polish Journal of Veterinary Sciences 2015; 18(1): 29 doi: 10.1515/pjvs-2015-0004
|
| 66 |
Hikmet Akkiz. The Emerging Role of MicroRNAs in
Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology 2014; 4(1): 45 doi: 10.5005/jp-journals-10018-1095
|
| 67 |
Antonio Concistrè, Luigi Petramala, Francesco Circosta, Priscilla Romagnoli, Maurizio Soldini, Marco Bucci, Domenico De Cesare, Giuseppe Cavallaro, Giorgio De Toma, Francesco Cipollone, Claudio Letizia. Analysis of the miRNA expression from the adipose tissue surrounding the adrenal neoplasia. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.930959
|
| 68 |
Ailbhe M. McDermott, Helen M. Heneghan, Nicola Miller, Michael J. Kerin. The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets. Pharmaceutical Research 2011; 28(12): 3016 doi: 10.1007/s11095-011-0550-2
|
| 69 |
Minyeoung Kweon, Jae Yeon Kim, Ji Hye Jun, Gi Jin Kim. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. International Journal of Molecular Sciences 2020; 22(1): 239 doi: 10.3390/ijms22010239
|
| 70 |
Tidi Hassan, Paul J McKiernan, Noel G McElvaney, Sally Ann Cryan, Catherine M Greene. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Expert Review of Anti-infective Therapy 2012; 10(3): 359 doi: 10.1586/eri.11.175
|
| 71 |
Yoonji Ha, Inju Jeong, Tae Hyun Kim. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 2022; 10(10): 2530 doi: 10.3390/biomedicines10102530
|
| 72 |
T. Kohno, M. Tsuge, E. Murakami, N. Hiraga, H. Abe, D. Miki, M. Imamura, H. Ochi, C. N. Hayes, K. Chayama. Human microRNA hsa‐miR‐1231 suppresses hepatitis B virus replication by targeting core mRNA. Journal of Viral Hepatitis 2014; 21(9) doi: 10.1111/jvh.12240
|
| 73 |
Baheti Kalifu, Abulaihaiti Maitiseyiti, Xiaohu Ge, Xiong Chen, Yuan Meng. Expression profile of circular RNAs in cystic echinococcosis pericystic tissue. Journal of Clinical Laboratory Analysis 2021; 35(3) doi: 10.1002/jcla.23687
|
| 74 |
Rajagopal N. Aravalli, Erik N. K. Cressman, Clifford J. Steer. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Archives of Toxicology 2013; 87(2): 227 doi: 10.1007/s00204-012-0931-2
|
| 75 |
R. Ranjha, J. Paul. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflammation Research 2013; 62(4): 343 doi: 10.1007/s00011-013-0600-9
|
| 76 |
|
| 77 |
Gábor Lendvai, András Kiss, Ilona Kovalszky, Zsuzsa Schaff. MicroRNAs in hepatocarcinogenesis. Orvosi Hetilap 2012; 153(25): 978 doi: 10.1556/OH.2012.29387
|
| 78 |
Ioannis Papaconstantinou, Andreas Karakatsanis, Maria Gazouli, George Polymeneas, Dionissios Voros. The role of microRNAs in liver cancer. European Journal of Gastroenterology & Hepatology 2012; 24(3): 223 doi: 10.1097/MEG.0b013e3283505063
|
| 79 |
Heibatullah Kalantari, Nooshin Asadmasjedi, Mohammad reza Abyaz, Masoud Mahdavinia, Narges Mohammadtaghvaei. Protective effect of inulin on methotrexate- induced liver toxicity in mice. Biomedicine & Pharmacotherapy 2019; 110: 943 doi: 10.1016/j.biopha.2018.11.144
|
| 80 |
Xiaozhen Zhang, Marybeth Daucher, David Armistead, Rodney Russell, Shyam Kottilil, Jinah Choi. MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α. PLoS ONE 2013; 8(2): e55733 doi: 10.1371/journal.pone.0055733
|
| 81 |
Min Ki Jee, Jin Sun Jung, Young Bin Im, Sung Jun Jung, Soo Kyung Kang. Silencing of miR20a Is Crucial for Ngn1-Mediated Neuroprotection in Injured Spinal Cord. Human Gene Therapy 2012; 23(5): 508 doi: 10.1089/hum.2011.121
|
| 82 |
Manuela G. Neuman, Samuel W. French, Barbara A. French, Helmut K. Seitz, Lawrence B. Cohen, Sebastian Mueller, Natalia A. Osna, Kusum K. Kharbanda, Devanshi Seth, Abraham Bautista, Kyle J. Thompson, Iain H. McKillop, Irina A. Kirpich, Craig J. McClain, Ramon Bataller, Radu M. Nanau, Mihai Voiculescu, Mihai Opris, Hong Shen, Brittany Tillman, Jun Li, Hui Liu, Paul G. Thomes, Murali Ganesan, Steve Malnick. Alcoholic and non-alcoholic steatohepatitis. Experimental and Molecular Pathology 2014; 97(3): 492 doi: 10.1016/j.yexmp.2014.09.005
|
| 83 |
Jennifer H. Benbow, Emilio Marrero, Rachel M. McGee, Elizabeth Brandon-Warner, Neha Attal, Nicole A. Feilen, Catherine R. Culberson, Iain H. McKillop, Laura W. Schrum. Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response. Experimental Cell Research 2021; 405(1): 112663 doi: 10.1016/j.yexcr.2021.112663
|
| 84 |
Shan-Gao Li, Jun Zhou, Ji-Hong Zhong, Hai-Jun Cao, Ling Zhu, Jun Liu, Hua-Jun Hu, Bin Lv. Effects of miR-9 and Tetramethylpyrazine on Activation of Hepatic Stellate Cells. Biological & Pharmaceutical Bulletin 2015; 38(3): 396 doi: 10.1248/bpb.b14-00611
|
| 85 |
Puth Muangpaisarn, Kanisa Jampoka, Sunchai Payungporn, Naruemon Wisedopas, Chalermrat Bunchorntavakul, Pisit Tangkijvanich, Sombat Treeprasertsuk. Serum microRNA-34a is potential biomarker for inflammation in nonalcoholic fatty liver disease. Asian Biomedicine 2017; 10(2): 163 doi: 10.5372/1905-7415.1002.478
|
| 86 |
Hai‐Di Li, Xiao‐Sa Du, Hui‐Min Huang, Xin Chen, Yang Yang, Cheng Huang, Xiao‐Ming Meng, Jun Li. Noncoding RNAs in alcoholic liver disease. Journal of Cellular Physiology 2019; 234(9): 14709 doi: 10.1002/jcp.28229
|
| 87 |
XIAOMING HUANG, ZHENYU JIA. Construction of HCC-targeting artificial miRNAs using natural miRNA precursors. Experimental and Therapeutic Medicine 2013; 6(1): 209 doi: 10.3892/etm.2013.1111
|
| 88 |
Erica Novo, Claudia Bocca, Beatrice Foglia, Francesca Protopapa, Marina Maggiora, Maurizio Parola, Stefania Cannito. Liver fibrogenesis: un update on established and emerging basic concepts. Archives of Biochemistry and Biophysics 2020; 689: 108445 doi: 10.1016/j.abb.2020.108445
|
| 89 |
Shashi K. Ramaiah. Preclinical Safety Assessment: Current Gaps, Challenges, and Approaches in Identifying Translatable Biomarkers of Drug-Induced Liver Injury. Clinics in Laboratory Medicine 2011; 31(1): 161 doi: 10.1016/j.cll.2010.10.004
|
| 90 |
Murali Ganesan, Sathish Kumar Natarajan, Jinjin Zhang, Justin L. Mott, Larisa I. Poluektova, Benita L. McVicker, Kusum K. Kharbanda, Dean J. Tuma, Natalia A. Osna. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(11): G930 doi: 10.1152/ajpgi.00021.2016
|
| 91 |
Saleh Al-Quraishy, Denis Delic, Helmult Sies, Frank Wunderlich, Abdel Azeem S. Abdel-Baki, Mohamed Abdel Monam Dkhil. Differential miRNA expression in the mouse jejunum during garlic treatment of Eimeria papillata infections. Parasitology Research 2011; 109(2): 387 doi: 10.1007/s00436-011-2266-y
|
| 92 |
Krishna K. Banaudha, Mukesh Verma. Cancer Epigenetics. Methods in Molecular Biology 2012; 863: 241 doi: 10.1007/978-1-61779-612-8_14
|
| 93 |
Andreas Karakatsanis, Ioannis Papaconstantinou, Maria Gazouli, Anna Lyberopoulou, George Polymeneas, Dionysios Voros. Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Molecular Carcinogenesis 2013; 52(4): 297 doi: 10.1002/mc.21864
|
| 94 |
Xing He, Xue Sai, Chao Chen, Yuanbin Zhang, Xindong Xu, Dongmei Zhang, Weiqing Pan. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy. Parasites & Vectors 2013; 6(1) doi: 10.1186/1756-3305-6-272
|
| 95 |
Pengyuan Zhang, Lijuan Xu, Hongyu Guan, Liehua Liu, Juan Liu, Zhimin Huang, Xiaopei Cao, Zhihong Liao, Haipeng Xiao, Yanbing Li. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway. Metabolism 2017; 73: 9 doi: 10.1016/j.metabol.2017.05.003
|
| 96 |
Anna Alisi, Letizia Da Sacco, Giovannella Bruscalupi, Fiorella Piemonte, Nadia Panera, Rita De Vito, Silvia Leoni, Gian Franco Bottazzo, Andrea Masotti, Valerio Nobili. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Laboratory Investigation 2011; 91(2): 283 doi: 10.1038/labinvest.2010.166
|
| 97 |
Ricardo C Gehrau, Valeria R Mas, Daniel G Maluf. Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?. Expert Review of Gastroenterology & Hepatology 2013; 7(2): 157 doi: 10.1586/egh.12.71
|
| 98 |
Elisabetta Ceni, Tommaso Mello, Andrea Galli. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World Journal of Gastroenterology 2014; 20(47): 17756-17772 doi: 10.3748/wjg.v20.i47.17756
|
| 99 |
Geon-Woo Kim, Seung-Hoon Lee, Hee Cho, Minwoo Kim, Eui-Cheol Shin, Jong-Won Oh, Timothy L. Tellinghuisen. Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. PLOS Pathogens 2016; 12(7): e1005714 doi: 10.1371/journal.ppat.1005714
|
| 100 |
Cui-Ling Ding, Gang Xu, Hao Ren, Lan-Juan Zhao, Ping Zhao, Zhong-Tian Qi, Wen Wang. HCV infection induces the upregulation of miR-221 in NF-κB dependent manner. Virus Research 2015; 196: 135 doi: 10.1016/j.virusres.2014.11.023
|
| 101 |
C. Hayes, Kazuaki Chayama. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(3): 280 doi: 10.3390/ijms17030280
|
| 102 |
H. M. Heneghan, N. Miller, O. J. McAnena, T. O'Brien, M. J. Kerin. Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers. The Journal of Clinical Endocrinology & Metabolism 2011; 96(5): E846 doi: 10.1210/jc.2010-2701
|
| 103 |
Marwa Zahra, Hassan Azzazy, Ahmed Moustafa. Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32464-5
|
| 104 |
Wei‐Qing Li, Chao Chen, Mi‐Die Xu, Jia Guo, Yi‐Ming Li, Qing‐Mei Xia, Hui‐Min Liu, Jin He, Hong‐Yu Yu, Liang Zhu. The rno‐miR‐34 family is upregulated and targets ACSL1 in dimethylnitrosamine‐induced hepatic fibrosis in rats. The FEBS Journal 2011; 278(9): 1522 doi: 10.1111/j.1742-4658.2011.08075.x
|
| 105 |
Keguang Chen, Ruichen Guo, Chunmin Wei. Synonymous Mutation rs2515641 Affects CYP2E1 mRNA and Protein Expression and Susceptibility to Drug-Induced Liver Injury. Pharmacogenomics 2020; 21(7): 459 doi: 10.2217/pgs-2019-0151
|
| 106 |
Virginia Hernandez-Gea, Scott L. Friedman. Pathogenesis of Liver Fibrosis. Annual Review of Pathology: Mechanisms of Disease 2011; 6(1): 425 doi: 10.1146/annurev-pathol-011110-130246
|
| 107 |
Fumiko Katsushima, Atsushi Takahashi, Natsumi Sakamoto, Yukiko Kanno, Kazumichi Abe, Hiromasa Ohira. Expression of micro‐RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatology Research 2014; 44(10) doi: 10.1111/hepr.12198
|
| 108 |
DONG SHAN YU, FANG MEI AN, BANG DONG GONG, XIAO GANG XIANG, LAN YI LIN, HUI WANG, QING XIE. The regulatory role of microRNA-1187 in TNF-α-mediated hepatocyte apoptosis in acute liver failure. International Journal of Molecular Medicine 2012; 29(4): 663 doi: 10.3892/ijmm.2012.888
|
| 109 |
Nury M. Steuerwald, Judith C. Parsons, Kristen Bennett, Tonya C. Bates, Herbert L. Bonkovsky. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus. Liver International 2010; 30(10): 1490 doi: 10.1111/j.1478-3231.2010.02321.x
|
| 110 |
Christiane Becker, Irmgard Riedmaier, Michael Pfaffl. PCR Technology. 2013; : 259 doi: 10.1201/b14930-24
|
| 111 |
Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. International Journal of Molecular Sciences 2018; 19(12): 3857 doi: 10.3390/ijms19123857
|
| 112 |
María Noelia Lardizábal, Ramiro Esteban Rodríguez, Ana Lía Nocito, Stella Maris Daniele, Javier Fernando Palatnik, Luis María Veggi. Alteration of the microRNA-122 regulatory network in rat models of hepatotoxicity. Environmental Toxicology and Pharmacology 2014; 37(1): 354 doi: 10.1016/j.etap.2013.12.008
|
| 113 |
Gyongyi Szabo, Peter Sarnow, Shashi Bala. MicroRNA silencing and the development of novel therapies for liver disease. Journal of Hepatology 2012; 57(2): 462 doi: 10.1016/j.jhep.2012.01.030
|
| 114 |
Peng-Sheng Yi, Ming Zhang, Ming-Qing Xu. Role of microRNA in liver regeneration. Hepatobiliary & Pancreatic Diseases International 2016; 15(2): 141 doi: 10.1016/S1499-3872(15)60036-4
|